nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—Parkinson's disease	0.769	1	CbGaD
Cyamemazine—HTR2A—enteric nervous system—Parkinson's disease	0.015	0.123	CbGeAlD
Cyamemazine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.0114	0.0935	CbGeAlD
Cyamemazine—HTR2A—locus ceruleus—Parkinson's disease	0.0099	0.0815	CbGeAlD
Cyamemazine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00936	0.077	CbGeAlD
Cyamemazine—HTR2A—cerebellar cortex—Parkinson's disease	0.00807	0.0664	CbGeAlD
Cyamemazine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00783	0.0644	CbGeAlD
Cyamemazine—HTR2A—pons—Parkinson's disease	0.00571	0.0469	CbGeAlD
Cyamemazine—HTR2A—autonomic nervous system—Parkinson's disease	0.00526	0.0433	CbGeAlD
Cyamemazine—HTR2A—telencephalic ventricle—Parkinson's disease	0.0047	0.0386	CbGeAlD
Cyamemazine—HTR2A—peripheral nervous system—Parkinson's disease	0.0038	0.0312	CbGeAlD
Cyamemazine—HTR2A—nerve—Parkinson's disease	0.00296	0.0243	CbGeAlD
Cyamemazine—CHRM2—forebrain—Parkinson's disease	0.00254	0.0209	CbGeAlD
Cyamemazine—HTR2C—brainstem—Parkinson's disease	0.00253	0.0208	CbGeAlD
Cyamemazine—HTR2C—forebrain—Parkinson's disease	0.00244	0.0201	CbGeAlD
Cyamemazine—HTR2A—hindbrain—Parkinson's disease	0.00222	0.0182	CbGeAlD
Cyamemazine—CHRM2—cardiovascular system—Parkinson's disease	0.00214	0.0176	CbGeAlD
Cyamemazine—HTR2C—medulla oblongata—Parkinson's disease	0.00177	0.0145	CbGeAlD
Cyamemazine—HTR2C—midbrain—Parkinson's disease	0.00161	0.0133	CbGeAlD
Cyamemazine—HTR2C—spinal cord—Parkinson's disease	0.00158	0.013	CbGeAlD
Cyamemazine—CHRM2—head—Parkinson's disease	0.00145	0.0119	CbGeAlD
Cyamemazine—HTR2C—head—Parkinson's disease	0.0014	0.0115	CbGeAlD
Cyamemazine—HTR2A—embryo—Parkinson's disease	0.00139	0.0114	CbGeAlD
Cyamemazine—CHRM2—nervous system—Parkinson's disease	0.00138	0.0113	CbGeAlD
Cyamemazine—HTR2C—nervous system—Parkinson's disease	0.00133	0.0109	CbGeAlD
Cyamemazine—CHRM2—central nervous system—Parkinson's disease	0.00133	0.0109	CbGeAlD
Cyamemazine—HTR2C—central nervous system—Parkinson's disease	0.00128	0.0105	CbGeAlD
Cyamemazine—HTR2A—brainstem—Parkinson's disease	0.00127	0.0105	CbGeAlD
Cyamemazine—HTR2A—forebrain—Parkinson's disease	0.00123	0.0101	CbGeAlD
Cyamemazine—CHRM2—brain—Parkinson's disease	0.00105	0.00866	CbGeAlD
Cyamemazine—HTR2A—cardiovascular system—Parkinson's disease	0.00104	0.00853	CbGeAlD
Cyamemazine—HTR2C—brain—Parkinson's disease	0.00101	0.00834	CbGeAlD
Cyamemazine—HTR2A—medulla oblongata—Parkinson's disease	0.000886	0.00729	CbGeAlD
Cyamemazine—HTR2A—midbrain—Parkinson's disease	0.00081	0.00666	CbGeAlD
Cyamemazine—HTR2A—spinal cord—Parkinson's disease	0.00079	0.0065	CbGeAlD
Cyamemazine—HTR2A—head—Parkinson's disease	0.000702	0.00578	CbGeAlD
Cyamemazine—HTR2A—nervous system—Parkinson's disease	0.000666	0.00548	CbGeAlD
Cyamemazine—HTR2A—central nervous system—Parkinson's disease	0.000641	0.00527	CbGeAlD
Cyamemazine—HTR2A—cerebellum—Parkinson's disease	0.000626	0.00515	CbGeAlD
Cyamemazine—HTR2A—brain—Parkinson's disease	0.000509	0.00419	CbGeAlD
Cyamemazine—Acetophenazine—DRD1—Parkinson's disease	0.000416	0.0303	CrCbGaD
Cyamemazine—Propericiazine—DRD1—Parkinson's disease	0.000368	0.0267	CrCbGaD
Cyamemazine—Acetophenazine—DRD2—Parkinson's disease	0.000294	0.0213	CrCbGaD
Cyamemazine—Triflupromazine—DRD1—Parkinson's disease	0.000255	0.0186	CrCbGaD
Cyamemazine—Clomipramine—GSTP1—Parkinson's disease	0.000238	0.0173	CrCbGaD
Cyamemazine—Acepromazine—DRD1—Parkinson's disease	0.000236	0.0172	CrCbGaD
Cyamemazine—Thioproperazine—DRD1—Parkinson's disease	0.000231	0.0168	CrCbGaD
Cyamemazine—Mesoridazine—DRD3—Parkinson's disease	0.000228	0.0166	CrCbGaD
Cyamemazine—Pipotiazine—DRD1—Parkinson's disease	0.000227	0.0165	CrCbGaD
Cyamemazine—Prochlorperazine—DRD3—Parkinson's disease	0.000221	0.0161	CrCbGaD
Cyamemazine—Fluphenazine—DRD3—Parkinson's disease	0.0002	0.0145	CrCbGaD
Cyamemazine—Fluphenazine—DRD1—Parkinson's disease	0.000196	0.0143	CrCbGaD
Cyamemazine—Acepromazine—HTR1A—Parkinson's disease	0.000196	0.0143	CrCbGaD
Cyamemazine—Thioproperazine—HTR1A—Parkinson's disease	0.000192	0.0139	CrCbGaD
Cyamemazine—Propiomazine—DRD1—Parkinson's disease	0.000189	0.0137	CrCbGaD
Cyamemazine—Pipotiazine—HTR1A—Parkinson's disease	0.000189	0.0137	CrCbGaD
Cyamemazine—Mesoridazine—HTR1A—Parkinson's disease	0.000186	0.0135	CrCbGaD
Cyamemazine—Thioridazine—HTR7—Parkinson's disease	0.000183	0.0133	CrCbGaD
Cyamemazine—Chlorprothixene—DRD3—Parkinson's disease	0.000182	0.0132	CrCbGaD
Cyamemazine—Triflupromazine—DRD2—Parkinson's disease	0.00018	0.0131	CrCbGaD
Cyamemazine—Chlorprothixene—DRD1—Parkinson's disease	0.000179	0.013	CrCbGaD
Cyamemazine—Thioridazine—DRD1—Parkinson's disease	0.000169	0.0123	CrCbGaD
Cyamemazine—Perphenazine—HTR7—Parkinson's disease	0.000168	0.0122	CrCbGaD
Cyamemazine—Acepromazine—DRD2—Parkinson's disease	0.000167	0.0121	CrCbGaD
Cyamemazine—Methotrimeprazine—DRD3—Parkinson's disease	0.000165	0.012	CrCbGaD
Cyamemazine—Fluphenazine—HTR1A—Parkinson's disease	0.000163	0.0119	CrCbGaD
Cyamemazine—Thioproperazine—DRD2—Parkinson's disease	0.000163	0.0118	CrCbGaD
Cyamemazine—Methotrimeprazine—DRD1—Parkinson's disease	0.000162	0.0117	CrCbGaD
Cyamemazine—Pipotiazine—DRD2—Parkinson's disease	0.00016	0.0116	CrCbGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00016	0.00167	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00016	0.00167	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00016	0.00167	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DGKQ—Parkinson's disease	0.000159	0.00167	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GPR37—Parkinson's disease	0.000159	0.00167	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000159	0.00167	CbGpPWpGaD
Cyamemazine—Mequitazine—CYP2D6—Parkinson's disease	0.000159	0.0116	CrCbGaD
Cyamemazine—Mesoridazine—DRD2—Parkinson's disease	0.000158	0.0115	CrCbGaD
Cyamemazine—Trimipramine—SLC6A3—Parkinson's disease	0.000157	0.0114	CrCbGaD
Cyamemazine—CHRM2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000157	0.00164	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GPR37—Parkinson's disease	0.000157	0.00164	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000156	0.00164	CbGpPWpGaD
Cyamemazine—Perphenazine—DRD1—Parkinson's disease	0.000155	0.0113	CrCbGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000154	0.00161	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GRK5—Parkinson's disease	0.000153	0.0016	CbGpPWpGaD
Cyamemazine—Prochlorperazine—DRD2—Parkinson's disease	0.000153	0.0111	CrCbGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.000152	0.00159	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000152	0.00159	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.000151	0.00158	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000146	0.00153	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000145	0.00151	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—HTR1A—Parkinson's disease	0.000145	0.00151	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000143	0.0015	CbGpPWpGaD
Cyamemazine—Diltiazem—CYP2D6—Parkinson's disease	0.000143	0.0104	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—TAC1—Parkinson's disease	0.000142	0.00149	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000142	0.00149	CbGpPWpGaD
Cyamemazine—Thioridazine—HTR1A—Parkinson's disease	0.000141	0.0102	CrCbGaD
Cyamemazine—Promazine—DRD1—Parkinson's disease	0.00014	0.0102	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD1—Parkinson's disease	0.00014	0.00146	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00014	0.00146	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00014	0.00146	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GRK5—Parkinson's disease	0.000139	0.00146	CbGpPWpGaD
Cyamemazine—Fluphenazine—DRD2—Parkinson's disease	0.000138	0.0101	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GRM4—Parkinson's disease	0.000137	0.00144	CbGpPWpGaD
Cyamemazine—Trimipramine—HTR1A—Parkinson's disease	0.000137	0.00998	CrCbGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000137	0.00143	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000137	0.00143	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD3—Parkinson's disease	0.000135	0.00142	CbGpPWpGaD
Cyamemazine—Chlorpromazine—HTR7—Parkinson's disease	0.000133	0.0097	CrCbGaD
Cyamemazine—Fluphenazine—CYP2E1—Parkinson's disease	0.000133	0.00969	CrCbGaD
Cyamemazine—Propiomazine—DRD2—Parkinson's disease	0.000133	0.00968	CrCbGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GRK5—Parkinson's disease	0.000133	0.00139	CbGpPWpGaD
Cyamemazine—Imipramine—HTR7—Parkinson's disease	0.000133	0.00965	CrCbGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000131	0.00137	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—VPS35—Parkinson's disease	0.000131	0.00137	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000131	0.00137	CbGpPWpGaD
Cyamemazine—Trifluoperazine—HTR1A—Parkinson's disease	0.00013	0.00948	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PENK—Parkinson's disease	0.00013	0.00136	CbGpPWpGaD
Cyamemazine—Perphenazine—HTR1A—Parkinson's disease	0.000129	0.00937	CrCbGaD
Cyamemazine—Acepromazine—HTR2A—Parkinson's disease	0.000129	0.00936	CrCbGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000129	0.00135	CbGpPWpGaD
Cyamemazine—Chlorprothixene—DRD2—Parkinson's disease	0.000126	0.00916	CrCbGaD
Cyamemazine—Thioproperazine—HTR2A—Parkinson's disease	0.000126	0.00915	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—HTR1A—Parkinson's disease	0.000126	0.00131	CbGpPWpGaD
Cyamemazine—Chlorpromazine—DRD3—Parkinson's disease	0.000126	0.00912	CrCbGaD
Cyamemazine—HTR2C—Signaling by GPCR—GRM4—Parkinson's disease	0.000125	0.00131	CbGpPWpGaD
Cyamemazine—Pipotiazine—HTR2A—Parkinson's disease	0.000124	0.009	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—TAC1—Parkinson's disease	0.000124	0.00129	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000123	0.00129	CbGpPWpGaD
Cyamemazine—Chlorpromazine—DRD1—Parkinson's disease	0.000123	0.00896	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD2—Parkinson's disease	0.000122	0.00128	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—HTR7—Parkinson's disease	0.000122	0.00128	CbGpPWpGaD
Cyamemazine—Mesoridazine—HTR2A—Parkinson's disease	0.000122	0.00888	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—TAC1—Parkinson's disease	0.000121	0.00127	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD1—Parkinson's disease	0.000121	0.00127	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GRK5—Parkinson's disease	0.000121	0.00126	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GRM4—Parkinson's disease	0.000119	0.00125	CbGpPWpGaD
Cyamemazine—Thioridazine—DRD2—Parkinson's disease	0.000119	0.00867	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PDYN—Parkinson's disease	0.000119	0.00125	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.000119	0.00125	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.000119	0.00124	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PENK—Parkinson's disease	0.000118	0.00124	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD3—Parkinson's disease	0.000118	0.00123	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000117	0.00123	CbGpPWpGaD
Cyamemazine—Trimipramine—DRD2—Parkinson's disease	0.000117	0.00847	CrCbGaD
Cyamemazine—Imipramine—SLC6A3—Parkinson's disease	0.000116	0.00845	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.000115	0.00121	CbGpPWpGaD
Cyamemazine—Thioridazine—CYP2E1—Parkinson's disease	0.000115	0.00835	CrCbGaD
Cyamemazine—Methotrimeprazine—DRD2—Parkinson's disease	0.000114	0.00828	CrCbGaD
Cyamemazine—HTR2A—Signaling Pathways—VPS35—Parkinson's disease	0.000114	0.00119	CbGpPWpGaD
Cyamemazine—Pipotiazine—CYP2D6—Parkinson's disease	0.000113	0.00823	CrCbGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PENK—Parkinson's disease	0.000113	0.00118	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000113	0.00118	CbGpPWpGaD
Cyamemazine—Promethazine—DRD2—Parkinson's disease	0.000112	0.00815	CrCbGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000112	0.00117	CbGpPWpGaD
Cyamemazine—Mesoridazine—CYP2D6—Parkinson's disease	0.000112	0.00812	CrCbGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000112	0.00117	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	0.000112	0.00117	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	0.000111	0.00116	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—GRM5—Parkinson's disease	0.000111	0.00116	CbGpPWpGaD
Cyamemazine—Trifluoperazine—DRD2—Parkinson's disease	0.000111	0.00805	CrCbGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00011	0.00115	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—CYP2E1—Parkinson's disease	0.00011	0.00797	CrCbGaD
Cyamemazine—Perphenazine—DRD2—Parkinson's disease	0.000109	0.00796	CrCbGaD
Cyamemazine—HTR2C—Signaling Pathways—GPR37—Parkinson's disease	0.000108	0.00114	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DGKQ—Parkinson's disease	0.000108	0.00114	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GRM4—Parkinson's disease	0.000108	0.00113	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PDYN—Parkinson's disease	0.000108	0.00113	CbGpPWpGaD
Cyamemazine—Prochlorperazine—CYP2D6—Parkinson's disease	0.000108	0.00786	CrCbGaD
Cyamemazine—Fluphenazine—HTR2A—Parkinson's disease	0.000107	0.00778	CrCbGaD
Cyamemazine—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	0.000106	0.00111	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD2—Parkinson's disease	0.000106	0.00111	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—HTR7—Parkinson's disease	0.000106	0.00111	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	0.000104	0.00109	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	0.000104	0.00109	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PDYN—Parkinson's disease	0.000104	0.00108	CbGpPWpGaD
Cyamemazine—Propiomazine—HTR2A—Parkinson's disease	0.000103	0.00748	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—PENK—Parkinson's disease	0.000103	0.00108	CbGpPWpGaD
Cyamemazine—Chlorpromazine—HTR1A—Parkinson's disease	0.000102	0.00744	CrCbGaD
Cyamemazine—Diltiazem—ABCB1—Parkinson's disease	0.000102	0.00741	CrCbGaD
Cyamemazine—Imipramine—HTR1A—Parkinson's disease	0.000102	0.0074	CrCbGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000102	0.00106	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000101	0.00106	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	0.000101	0.00106	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000101	0.00106	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—GRM5—Parkinson's disease	0.000101	0.00105	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	9.93e-05	0.00104	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PPP1R1B—Parkinson's disease	9.92e-05	0.00104	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	9.91e-05	0.00104	CbGpPWpGaD
Cyamemazine—Promazine—DRD2—Parkinson's disease	9.87e-05	0.00717	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—EDN1—Parkinson's disease	9.8e-05	0.00103	CbGpPWpGaD
Cyamemazine—Clomipramine—HTR2A—Parkinson's disease	9.79e-05	0.00711	CrCbGaD
Cyamemazine—Fluphenazine—CYP2D6—Parkinson's disease	9.78e-05	0.00711	CrCbGaD
Cyamemazine—Chlorprothixene—HTR2A—Parkinson's disease	9.74e-05	0.00708	CrCbGaD
Cyamemazine—HTR2A—GPCR downstream signaling—GRM5—Parkinson's disease	9.62e-05	0.00101	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	9.6e-05	0.001	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	9.45e-05	0.000988	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADORA2A—Parkinson's disease	9.42e-05	0.000986	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DGKQ—Parkinson's disease	9.42e-05	0.000986	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GPR37—Parkinson's disease	9.42e-05	0.000986	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PDYN—Parkinson's disease	9.4e-05	0.000983	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	9.25e-05	0.000968	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	9.25e-05	0.000968	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	9.23e-05	0.000966	CbGpPWpGaD
Cyamemazine—Thioridazine—HTR2A—Parkinson's disease	9.22e-05	0.0067	CrCbGaD
Cyamemazine—Triflupromazine—ABCB1—Parkinson's disease	9.09e-05	0.0066	CrCbGaD
Cyamemazine—Trimipramine—HTR2A—Parkinson's disease	9e-05	0.00654	CrCbGaD
Cyamemazine—Clomipramine—CYP2D6—Parkinson's disease	8.95e-05	0.0065	CrCbGaD
Cyamemazine—Methotrimeprazine—HTR2A—Parkinson's disease	8.8e-05	0.0064	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—GRM5—Parkinson's disease	8.74e-05	0.000914	CbGpPWpGaD
Cyamemazine—Chlorpromazine—DRD2—Parkinson's disease	8.69e-05	0.00631	CrCbGaD
Cyamemazine—HTR2C—Signaling Pathways—RIT2—Parkinson's disease	8.67e-05	0.000907	CbGpPWpGaD
Cyamemazine—Promethazine—HTR2A—Parkinson's disease	8.67e-05	0.0063	CrCbGaD
Cyamemazine—Imipramine—DRD2—Parkinson's disease	8.64e-05	0.00628	CrCbGaD
Cyamemazine—HTR2A—Signaling Pathways—PPP1R1B—Parkinson's disease	8.62e-05	0.000901	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	8.58e-05	0.000898	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—HTR2A—Parkinson's disease	8.57e-05	0.000897	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADORA2A—Parkinson's disease	8.56e-05	0.000895	CbGpPWpGaD
Cyamemazine—Trifluoperazine—HTR2A—Parkinson's disease	8.55e-05	0.00622	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—EDN1—Parkinson's disease	8.51e-05	0.00089	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	8.46e-05	0.000885	CbGpPWpGaD
Cyamemazine—Perphenazine—HTR2A—Parkinson's disease	8.46e-05	0.00615	CrCbGaD
Cyamemazine—Thioridazine—CYP2D6—Parkinson's disease	8.43e-05	0.00613	CrCbGaD
Cyamemazine—Chlorpromazine—CYP2E1—Parkinson's disease	8.36e-05	0.00608	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	8.35e-05	0.000874	CbGpPWpGaD
Cyamemazine—Imipramine—CYP2E1—Parkinson's disease	8.32e-05	0.00605	CrCbGaD
Cyamemazine—Trimipramine—CYP2D6—Parkinson's disease	8.23e-05	0.00598	CrCbGaD
Cyamemazine—HTR2C—Signaling Pathways—GRK5—Parkinson's disease	8.22e-05	0.00086	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.18e-05	0.000856	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HTR1A—Parkinson's disease	8.18e-05	0.000855	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—TAC1—Parkinson's disease	8.05e-05	0.000842	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—CYP2D6—Parkinson's disease	8.05e-05	0.00585	CrCbGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.03e-05	0.00084	CbGpPWpGaD
Cyamemazine—Promethazine—CYP2D6—Parkinson's disease	7.93e-05	0.00576	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD1—Parkinson's disease	7.9e-05	0.000826	CbGpPWpGaD
Cyamemazine—Perphenazine—CYP2D6—Parkinson's disease	7.74e-05	0.00562	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD3—Parkinson's disease	7.65e-05	0.0008	CbGpPWpGaD
Cyamemazine—Promazine—HTR2A—Parkinson's disease	7.63e-05	0.00554	CrCbGaD
Cyamemazine—HTR2A—Signaling Pathways—RIT2—Parkinson's disease	7.53e-05	0.000788	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADORA2A—Parkinson's disease	7.43e-05	0.000777	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HTR1A—Parkinson's disease	7.42e-05	0.000777	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	7.4e-05	0.000774	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GRM4—Parkinson's disease	7.38e-05	0.000772	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.34e-05	0.000768	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—TAC1—Parkinson's disease	7.31e-05	0.000765	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	7.31e-05	0.000765	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	7.3e-05	0.000763	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.2e-05	0.000754	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD1—Parkinson's disease	7.17e-05	0.00075	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.14e-05	0.000747	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GRK5—Parkinson's disease	7.14e-05	0.000747	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—HTR1A—Parkinson's disease	7.1e-05	0.000743	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	7.01e-05	0.000733	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—TAC1—Parkinson's disease	6.99e-05	0.000731	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAG—Parkinson's disease	6.99e-05	0.000731	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PENK—Parkinson's disease	6.99e-05	0.000731	CbGpPWpGaD
Cyamemazine—Fluphenazine—ABCB1—Parkinson's disease	6.99e-05	0.00508	CrCbGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	6.97e-05	0.000729	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD3—Parkinson's disease	6.94e-05	0.000727	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD2—Parkinson's disease	6.92e-05	0.000724	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HTR7—Parkinson's disease	6.92e-05	0.000724	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	6.87e-05	0.000718	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD1—Parkinson's disease	6.86e-05	0.000717	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	6.73e-05	0.000704	CbGpPWpGaD
Cyamemazine—Chlorpromazine—HTR2A—Parkinson's disease	6.71e-05	0.00488	CrCbGaD
Cyamemazine—Imipramine—HTR2A—Parkinson's disease	6.68e-05	0.00485	CrCbGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD3—Parkinson's disease	6.64e-05	0.000695	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	6.52e-05	0.000682	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—ADRBK1—Parkinson's disease	6.48e-05	0.000678	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—HTR1A—Parkinson's disease	6.45e-05	0.000674	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GRM4—Parkinson's disease	6.4e-05	0.00067	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PDYN—Parkinson's disease	6.39e-05	0.000669	CbGpPWpGaD
Cyamemazine—Clomipramine—ABCB1—Parkinson's disease	6.39e-05	0.00464	CrCbGaD
Cyamemazine—Chlorprothixene—ABCB1—Parkinson's disease	6.36e-05	0.00462	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—TAC1—Parkinson's disease	6.35e-05	0.000664	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	6.33e-05	0.000662	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	6.29e-05	0.000658	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HTR7—Parkinson's disease	6.28e-05	0.000657	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD2—Parkinson's disease	6.28e-05	0.000657	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	6.23e-05	0.000652	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD1—Parkinson's disease	6.23e-05	0.000651	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.2e-05	0.000649	CbGpPWpGaD
Cyamemazine—Chlorpromazine—CYP2D6—Parkinson's disease	6.14e-05	0.00446	CrCbGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	6.11e-05	0.00064	CbGpPWpGaD
Cyamemazine—Imipramine—CYP2D6—Parkinson's disease	6.11e-05	0.00444	CrCbGaD
Cyamemazine—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.09e-05	0.000637	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAG—Parkinson's disease	6.07e-05	0.000635	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PENK—Parkinson's disease	6.07e-05	0.000635	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	6.03e-05	0.000631	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GFAP—Parkinson's disease	6.01e-05	0.000629	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	6.01e-05	0.000628	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	6.01e-05	0.000628	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	5.96e-05	0.000624	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	5.96e-05	0.000624	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GRM5—Parkinson's disease	5.94e-05	0.000622	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	5.92e-05	0.000619	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.92e-05	0.000619	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	5.9e-05	0.000617	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	5.9e-05	0.000617	CbGpPWpGaD
Cyamemazine—Trimipramine—ABCB1—Parkinson's disease	5.88e-05	0.00427	CrCbGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.81e-05	0.000608	CbGpPWpGaD
Cyamemazine—Promethazine—ABCB1—Parkinson's disease	5.66e-05	0.00411	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	5.63e-05	0.000589	CbGpPWpGaD
Cyamemazine—Trifluoperazine—ABCB1—Parkinson's disease	5.59e-05	0.00406	CrCbGaD
Cyamemazine—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	5.55e-05	0.000581	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—EDN1—Parkinson's disease	5.54e-05	0.000579	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	5.53e-05	0.000578	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	5.45e-05	0.000571	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	5.45e-05	0.000571	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	5.45e-05	0.00057	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	5.35e-05	0.00056	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	5.35e-05	0.00056	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	5.28e-05	0.000552	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	5.22e-05	0.000546	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGF20—Parkinson's disease	5.21e-05	0.000545	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	5.16e-05	0.00054	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	5.13e-05	0.000536	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	5.07e-05	0.00053	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADORA2A—Parkinson's disease	5.05e-05	0.000529	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—EDN1—Parkinson's disease	5.03e-05	0.000526	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	4.84e-05	0.000507	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	4.81e-05	0.000503	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	4.72e-05	0.000494	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—INSR—Parkinson's disease	4.66e-05	0.000488	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.58e-05	0.000479	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	4.53e-05	0.000474	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	4.44e-05	0.000465	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGB—Parkinson's disease	4.41e-05	0.000461	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	4.4e-05	0.00046	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	4.39e-05	0.000459	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	4.39e-05	0.000459	CbGpPWpGaD
Cyamemazine—Chlorpromazine—ABCB1—Parkinson's disease	4.38e-05	0.00319	CrCbGaD
Cyamemazine—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	4.37e-05	0.000457	CbGpPWpGaD
Cyamemazine—Imipramine—ABCB1—Parkinson's disease	4.36e-05	0.00317	CrCbGaD
Cyamemazine—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	4.32e-05	0.000452	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	4.31e-05	0.000451	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	4.29e-05	0.000448	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	4.24e-05	0.000443	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	4.13e-05	0.000432	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	4.1e-05	0.000429	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—INSR—Parkinson's disease	4.05e-05	0.000424	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	3.98e-05	0.000416	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	3.83e-05	0.000401	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	3.83e-05	0.000401	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	3.81e-05	0.000398	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	3.76e-05	0.000393	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	3.75e-05	0.000392	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	3.75e-05	0.000392	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	3.74e-05	0.000391	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	3.71e-05	0.000388	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	3.71e-05	0.000388	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	3.68e-05	0.000385	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	3.68e-05	0.000385	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	3.61e-05	0.000378	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	3.56e-05	0.000373	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	3.5e-05	0.000366	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	3.33e-05	0.000348	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	3.27e-05	0.000342	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	3.22e-05	0.000337	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	3.22e-05	0.000337	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	3.16e-05	0.000331	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	3.16e-05	0.000331	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	3.11e-05	0.000325	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	3.01e-05	0.000314	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	2.97e-05	0.000311	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	2.73e-05	0.000286	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	2.7e-05	0.000282	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	2.65e-05	0.000277	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	2.61e-05	0.000273	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	2.6e-05	0.000272	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	2.58e-05	0.00027	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	2.56e-05	0.000268	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	2.53e-05	0.000265	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	2.42e-05	0.000253	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	2.37e-05	0.000248	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.33e-05	0.000243	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	2.22e-05	0.000232	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	2.1e-05	0.000219	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—INS—Parkinson's disease	2.06e-05	0.000216	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.06e-05	0.000215	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—INS—Parkinson's disease	1.79e-05	0.000187	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—INS—Parkinson's disease	1.76e-05	0.000184	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	1.54e-05	0.000161	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	1.53e-05	0.00016	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	1.41e-05	0.000148	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	1.33e-05	0.00014	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	1.33e-05	0.000139	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.31e-05	0.000137	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.3e-05	0.000136	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	1.23e-05	0.000128	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.2e-05	0.000126	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	9.02e-06	9.43e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	7.83e-06	8.19e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	7.69e-06	8.04e-05	CbGpPWpGaD
